News
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation...
During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health...
Ever since Crispr-Cas9 gene-editing technology emerged in the early 2010s, ethical questions around genetically altered humans, so-called designer babies, have...
Researchers have created what they say may count as the first synthetic cell, and have started a public benefit corporation...
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team...
Birthrates in much of the developed world are at record lows, but there’s one demographic group that’s exploring new frontiers...
A research program at the National Institutes of Health released the world’s largest database of human genomes and paired them...
In 2017, a 33-year-old political philosopher named Iason Gabriel was told by a friend that he ought to apply for a...
The US Food and Drug Administration (FDA) is allowing biotech company Regenxbio to reapply for licensing of a gene therapy...
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by...